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        Chemokine-induced recruitment of peripheral 
blood leukocytes to tissues is a critical step in 
development of infl  ammatory responses. Hence, 
specifi  c inhibition of leukocyte migration is 
envisaged as a rational therapeutic approach for 
infl  ammatory diseases (  1  ). Monocyte chemo-
attractant protein-1 (MCP-1), which is a critical 
ligand for monocyte chemotaxis, binds to its re-
ceptor CC chemokine receptor 2 (CCR2) and 
recruits monocytes to infl  amed sites in a variety of 
chronic infl  ammatory diseases, such as athero-
sclerosis, multiple sclerosis, rheumatoid arthritis, 
and Alzheimer  ’  s disease (  2  ). MCP-1 or CCR2 
knockout mice exhibited a severe reduction in 
monocyte chemotaxis to thioglycolate-induced 
peritonitis and resistance to atherosclerosis (  3  –  8  ), 
suggesting that MCP-1 and CCR2 are re-
quired for monocyte migration in both health 
and disease. 
  Despite the signifi  cance of MCP-1 and mono-
cytes in the pathogenesis of infl  ammatory diseases, 
our understanding of how MCP-1 transforms 
random migration of monocytes to directed 
migration is limited to identifi  cation of a few 
regulatory signaling molecules. These include 
pho  spholipase C (  9  ), Src, Syk, MAPKs p42/
44ERK1/2, p38, JNK (  10  ), Pyk2 (unpublished 
data), phosphatidylinositol 3-kinase (PI3K) (  11  ), 
protein kinase C      (  12  ), and association of Arp2/3 
with Wiskott-Aldrich syndrome protein (  13  ). 
Earlier, we discovered Ca  2+  -independent phos-
pholipase (iPLA  2       ) and cytosolic phospholipase 
(cPLA  2       ) as critical regulators of monocyte che-
motaxis to MCP-1. Monocytes rendered defi  -
cient in iPLA  2        by treatment with antisense 
oligodeoxyribonucleotides (ODNs) displayed 
normal cPLA  2        activity, and vice versa. Further-
more, monocytes rendered defi  cient in iPLA  2        
or cPLA  2        by their antisense ODNs are re-
stored for chemotaxis to MCP-1 if treated with 
lysophosphatidic acid (LPA) or arachidonic acid 
(AA), respectively, yet both enzymes are re-
quired for monocyte chemotaxis to MCP-1 
(  14  ). These observations led us to hypothesize 
that iPLA  2        and cPLA  2        might be recruited to 
diff  erent intracellular locations, and that they 
might regulate distinct properties of monocyte 
chemotaxis to MCP-1. In this study, we tested 
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  Monocyte chemoattractant protein-1 (MCP-1) directs migration of blood monocytes to 
infl  amed tissues. Despite the central role of chemotaxis in immune responses, the regula-
tion of chemotaxis by signal transduction pathways and their in vivo signifi  cance remain to 
be thoroughly deciphered. In this study, we examined the intracellular location and func-
tions of two recently identifi  ed regulators of chemotaxis, Ca  2+  -independent phospholipase 
(iPLA  2       ) and cytosolic phospholipase (cPLA  2       ), and substantiate their in vivo importance. 
These enzymes are cytoplasmic in unstimulated monocytes. Upon MCP-1 stimulation, 
iPLA  2        is recruited to the membrane-enriched pseudopod. In contrast, cPLA  2        is recruited 
to the endoplasmic reticulum. Although iPLA  2        or cPLA  2        antisense oligodeoxyribonucleo-
tide (ODN)  –  treated monocytes display reduced speed, iPLA  2        also regulates directionality 
and actin polymerization. iPLA  2        or cPLA  2        antisense ODN  –  treated adoptively transferred 
mouse monocytes display a profound defect in migration to the peritoneum in vivo. These 
converging observations reveal that iPLA  2        and cPLA  2        regulate monocyte migration from 
different intracellular locations, with iPLA  2        acting as a critical regulator of the cellular 
compass, and identify them as potential targets for antiinfl  ammatory strategies. 348 PHOSPHOLIPASES IN MONOCYTE CHEMOTAXIS TO MCP-1 | Mishra et al.
F-actin with iPLA  2        was not dependent on the polar mor-
phology of monocytes (  Fig. 1 D  , fi  lled versus black-hatched bar), 
and that it correlated with signifi  cantly enhanced colocal-
ization of iPLA  2        with Cdc42 (  Fig. 1 E and 1F  ). Together, 
these results show that MCP-1 induces redistribution of 
iPLA  2        in nonpolar monocytes that eventually culminates 
in the increased presence of iPLA  2        in the pseudopod of 
polar monocytes. 
  Association of iPLA  2        with the cell membrane was evalu-
ated by visualizing the colocalization of iPLA  2        with Na-K-
ATPase (  Fig. 1 G  ). Quantitative evaluation suggested that 
MCP-1  –  treated polar monocytes displayed signifi  cantly higher 
colocalization of iPLA  2        with Na-K-ATPase compared with 
untreated monocytes ( Fig. 1 H ). To rule out the possibility that 
this was an artifact caused by the small size of the monocytes, 
the percentage distribution of iPLA  2        associated with the cell 
membrane was also determined by quantifying pixel intensity 
of iPLA  2        on the peripheral cell membrane and in the whole 
cell (  17  ). As shown in Fig. S1 (available at http://www.jem
.org/cgi/content/full/jem.20071243/DC1), MCP-1 induced 
approximately twofold induction of iPLA  2        recruitment to 
the cell membrane in both polar or nonpolar monocytes, sug-
gesting that recruitment of iPLA  2        to the cell membrane is 
specifi  cally induced by MCP-1, regardless of cell polarity. 
  cPLA  2        is recruited to the endoplasmic reticulum.     Be-
cause of the stimulus and cell type  –  dependent variability in 
intracellular locations of cPLA  2       , we initially explored the 
recruitment of cPLA  2        to early endosomes, Golgi, and endo-
plasmic reticulum by costaining with Rab 5, lectin GS-II, 
and protein disulfi  de isomerase (PDI), respectively. cPLA  2        
showed minimal or no localization with the Golgi or early 
endosomes (unpublished data). In the absence of MCP-1, 
cPLA  2        was distributed throughout the cytoplasm (  Fig. 2 A  , left) 
and did not reveal specifi  c colocalization with PDI (  Fig. 2 A  , 
arrowhead).   In MCP-1  –  stimulated cells, cPLA  2        was con-
centrated in the posterior region of the cell and colocalized 
with PDI (  Fig. 2 A  , right). MCP-1 induced a signifi  cant 
increase in recruitment of cPLA  2        to the endoplasmic reticu-
lum, irrespective of cell polarity (  Fig. 2 B  , fi  lled versus black-
hatched bar). 
  iPLA  2        and cPLA  2        do not colocalize.     To further substan-
tiate that MCP-1 induces localization of iPLA  2        and cPLA  2        
to diff  erent intracellular sites, both enzymes were visualized 
together, and the percentage of colocalization of the phos-
pholipases was determined. In MCP-1 –  stimulated monocytes, 
cPLA  2        was concentrated in the posterior main body of the 
cell; in contrast, iPLA  2        was concentrated in the pseudopod 
(  Fig. 2 C  , right, merged image). Furthermore, the cPLA  2       -
rich posterior region was relatively devoid of iPLA  2        staining, 
whereas the iPLA  2       -enriched pseudopod showed minimal 
cPLA  2        staining (  Fig. 2 C  , right, merged image, arrow versus 
arrowhead). The colocalization of iPLA  2        with cPLA  2        
(28   ±   6%), or vice versa (32   ±   6%), remained statistically un-
altered because of MCP-1 treatment (  Fig. 2 D  ). 
these possibilities by examining MCP-1  –  induced redistribution 
of these phospholipases and by evaluating their contributions 
to the characteristics of monocyte chemotaxis to MCP-1. 
We report that MCP-1 induces iPLA  2        recruitment to the 
membrane-enriched pseudopod, whereas cPLA  2        is recruited 
to the endoplasmic reticulum. Although both enzymes regu-
late speed and net migration of monocytes toward MCP-1, 
directionality is governed by iPLA  2       , likely by regulating 
F-actin polymerization. Finally, we validate the requirement 
for both of these phospholipases for monocyte chemotaxis in 
vivo using a novel mouse model. 
    RESULTS   
  iPLA  2        regulates monocyte chemotaxis to MCP-1 
  The antisense oligodeoxyribonucleotides (AS-ODN) used 
in our previous study to identify the involvement of iPLA  2   
was directed against the form of iPLA  2   that was eventually 
classifi  ed as iPLA  2        (  14  ). iPLA  2   isoforms (     /     ) display dif-
ferent sensitivities to R or S enantiomers of the pharmacolog-
ical inhibitor bromoenol lactone (BEL), with iPLA  2        being 
10 times more sensitive to (S)-BEL than to (R)-BEL (  15  ). 
As predicted, (S)-BEL caused stronger reduction of MCP-1  –
  induced monocyte chemotaxis compared with (R)-BEL at 
all concentrations tested, providing additional evidence that 
monocyte chemotaxis to MCP-1 is indeed regulated by 
iPLA  2        (  Fig. 1 A  ).   
  iPLA  2        and cPLA  2        are recruited to different intracellular 
sites in response to MCP-1 
  iPLA  2        is recruited to the plasma membrane and the 
pseudopod.     Unstimulated monocytes showed diff  erent 
morphologies that varied from spherical to polar with diff  use, 
cytoplasmic iPLA  2        staining (  Fig. 1, C, E, and G  , left). Upon 
MCP-1 stimulation, migrating cells displayed polar morphol-
ogy, and iPLA  2        showed increased distribution at the cell pe-
riphery, particularly in the membrane-enriched pseudopod 
(  Fig. 1, C, E, G  , right). Quantifi  cation of mean fl  uorescent 
intensity of iPLA  2        in the tail, midbody, and pseudopod of 
migrating monocytes suggests that, in the absence of MCP-1, 
iPLA  2        was localized predominantly in the tail of monocytes; 
however, in response to MCP-1, the distribution was reversed 
and the majority of iPLA  2        was detected in the pseudopod of 
moving cells (  Fig. 1 B  ). These observations demonstrate that 
MCP-1 induces preferential recruitment of iPLA  2        from the 
tail to the pseudopod of migrating monocytes. 
  Because MCP-1  –  induced chemotaxis of iPLA  2       -defi  cient 
cells could be rescued with LPA (  14  ), which is known to 
induce focal adhesion assembly (  16  ), it is likely that iPLA  2        
aff  ects monocyte migration by interacting with an essential 
component of the pseudopod. Therefore, we evaluated the 
colocalization of iPLA  2        with F-actin and Cdc42, which are 
two known markers of the pseudopod (  Fig. 1, C and E  ). In the 
presence of MCP-1, F-actin was enriched in the pseudopod of 
migrating monocytes and showed increased colocalization with 
iPLA  2        (  Fig. 1 C  , right, merged image). Quantitative evaluation 
showed that the MCP-1  –  induced increased colocalization of JEM VOL. 205, February 18, 2008 
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    Figure 1.          MCP-1 induces recruitment of iPLA  2        to the cell membrane  –  enriched pseudopod of monocytes.   (A) To identify the iPLA  2  isoform 
regulating monocyte chemotaxis to MCP-1, monocytes were treated with racemic–BEL (     ), (R)-BEL (     ), or (S)–BEL (     ) at various concentrations (as 
indicated) for 1 h at 37  °  C. Chemotaxis to MCP-1 was assessed using the microchamber assay. Migration of untreated monocytes in the presence (     ) and 
absence (     ) of MCP-1 were used as controls. (B) MCP-1 induces redistribution of iPLA  2     . The mean fl  uorescent intensity of iPLA  2      in the tail, midbody, 
and pseudopod of polar monocytes, either in the presence or absence of MCP-1, was determined. Data represent the mean   ±   the SEM of 40  –  50 mono-
cytes from 3 independent experiments. (C  –  H) Colocalization iPLA  2      (Alexa Fluor 488) and F-actin, Cdc42, or Na-K ATPase (Alexa Fluor 594) was visualized 
by observing the distribution of chromophores in a single plane passing through the nucleus. Nuclei were stained with DAPI. Cell morphology was deter-
mined by DIC images and statistical analysis was performed using Student’s   t   test (two-tailed). Bars, 10      m. (C) MCP-1  –  induced translocation of iPLA  2      
to the pseudopod and localization with F-actin. (D) The effect of MCP-1 on colocalization of iPLA  2      with F-actin was quantifi  ed in polar and nonpolar 
monocytes. Data are the mean   ±   the SEM of 40  –  50 monocytes.   n   = 3. (E) MCP-1 induced the translocation of iPLA  2      to the pseudopod and colocalization 
with Cdc42. (F) Colocalization (percentage) of iPLA  2      with Cdc42 in nonpolar and polar monocytes was quantifi  ed. Data represent the mean   ±   the SEM of 
40 – 50  monocytes.   n   = 3. (G) MCP-1 induced the recruitment of iPLA  2      to the cell membrane as visualized with Na-K-ATPase. (H) The quantitative co-
localization of iPLA  2      with Na-K-ATPase was determined. Monocytes (10  –  20) from three different experiments were used.     350 PHOSPHOLIPASES IN MONOCYTE CHEMOTAXIS TO MCP-1 | Mishra et al.
used previously characterized antisense ODNs to assess the 
eff  ect of iPLA  2        and cPLA  2        defi  ciency on MCP-1  –  induced 
chemotaxis of monocytes. It is important to note that these 
antisense ODNs have been shown to specifi  cally target these 
enzymes and do not modulate the expression of CCR2 (  14, 
18, 19  ). Monocytes were allowed to respond to MCP-1 for 
1 h, fi  xed, and analyzed for net distance. Net distance was deter-
mined by measuring the distance of all migrated cells from the 
periphery of the well to their fi  nal position, and it refl  ects the 
cumulative eff  ect of change in speed and direction. As shown 
(  Fig. 3  ), MCP-1 increased the chemotaxis of monocytes and 
the migrated cells traveled to 1.82-fold greater net distance 
  In summary, microscopic observations reveal that MCP-1 
induces redistribution of both enzymes; cPLA  2        is recruited 
to the endoplasmic reticulum, whereas iPLA  2        is recruited to 
the membrane-enriched pseudopod of monocytes, and these 
phospholipases do not colocalize. 
  iPLA  2        and cPLA  2        regulate MCP-1  –  induced net distance 
of monocyte migration 
  To gather insight as to how cPLA  2        and iPLA  2        modify che-
motaxis of monocytes to MCP-1, we evaluated their eff  ects 
on the net distance traveled by monocytes in a gradient of 
MCP-1 using an under-agarose assay. For these studies, we 
    Figure 2.         MCP-1 induces translocation of cPLA  2            to the endoplasmic reticulum.   (A)  cPLA 2      (green) distribution with the endoplasmic reticulum 
marker PDI (red). Specifi  c colocalization of cPLA  2      with PDI is shown with the white arrow; arrowhead shows an area of no colocalization. (B) Quantita-
tion of colocalization of cPLA  2      with PDI. Data represent the mean   ±   the SEM of 60 monocytes from three independent experiments. Signifi  cance was 
calculated by an unpaired and two-tailed Student  ’  s   t   test. (C) MCP-1  –  induced differential recruitment of cPLA  2      (red) and iPLA  2      (green). (D) Colocalization 
(percentage) of cPLA  2      with  iPLA 2     , and vice versa, in the same group of monocytes from three independent experiments. Data were plotted as the 
mean   ±   the SEM. Statistical signifi  cance was determined using an unpaired, two-tailed Student  ’  s   t   test. Bars, 10     m.   JEM VOL. 205, February 18, 2008 
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parameters was delineated by quantitative analysis of time-
lapse photomicrographs. 
  As shown in wind-rose plots (  Fig. 4 A  ), in the absence of 
MCP-1, monocytes showed random migration (top left).   
Upon MCP-1 stimulation, cells migrated toward the source 
of MCP-1 and traveled longer distances (bottom left). Cells 
treated with sense ODN to iPLA  2        migrated similarly to un-
treated cells (  Fig. 4 A  , middle). Interestingly, monocytes 
treated with iPLA  2        antisense ODN showed a more clus-
tered migratory pattern both in the absence or presence of 
MCP-1 (  Fig. 4 A  , right top and bottom). Quantitative analysis 
of all cells that could be tracked for 60 min (  n  ) revealed that in 
response to MCP-1, monocytes migrated signifi  cantly faster 
than unstimulated monocytes and equally to sense ODN  –
  treated cells (  Fig. 4 A  ). In contrast, treatment of monocytes 
with antisense ODN to iPLA  2        signifi  cantly decreased the 
speed of migrating monocytes from 7.58   ±   0.62 to 5.93   ±   
0.49 m/min (  Fig. 4 A  ). Furthermore, iPLA  2        antisense ODN  –
  treated cells showed a signifi  cant reduction in net distance, 
whereas the net distance traveled by sense ODN-treated mono-
cytes remained unaltered (  Fig. 4 C  ). These fi  ndings confi  rm 
the results presented in   Fig. 3  . 
  We reasoned that speed or net distance merely refl  ect 
migration of monocytes, irrespective of their direction. In con-
trast, the ability of monocytes to reach infl  amed sites depends 
on their ability to navigate toward the source of MCP-1. 
Hence, the contribution of iPLA  2        in directed migration of 
monocytes toward MCP-1 was determined by quantifi  cation 
of net-X distance that denotes the net value of the X coordi-
nate toward MCP-1. As shown in   Fig. 4 D  , MCP-1 induced 
a fi  vefold induction in net-X. Treatment of monocytes with 
sense ODN to iPLA  2        had no eff  ect; in contrast, monocytes 
treated with antisense ODN to iPLA  2        displayed signifi  cant 
reduction in net-X. 
  To further probe whether the loss of directionality contrib-
uted to the reduced net-X distance (  Fig. 4 D  ) and clustered mi-
gratory pattern of iPLA  2        antisense ODN-treated monocytes 
(  Fig. 4 A  , bottom right), turn analysis was performed. As shown 
in   Fig. 4 E  , MCP-1  –  treated monocytes make fewer wide turns 
(  ≥  30 degrees, 9   ±   0.81), which is similar to monocytes treated 
with sense ODN to iPLA  2        (9.66   ±   0.76). In contrast, iPLA  2        
antisense ODN  –  treated monocytes make more frequent wide 
turns (  >  30 degrees, 14.2   ±   1.39). The MCP-1  –  stimulated 
mono  cytes without the ODN treatment showed a signifi  cant 
reduction in average angle per turn from 71.08   ±   7.37 to 35.54   ±   
4.18 degrees compared with monocytes without MCP-1 
(  Fig. 4 F  ). This eff  ect was totally abrogated in iPLA  2        antisense 
ODN  –  treated monocytes (  Fig. 4 F  ), suggesting that iPLA  2        is 
a contributor to the cellular compass. 
  cPLA  2        regulates only the speed of monocyte chemotaxis
to MCP-1 
  As shown in   Fig. 5 A  , wind-rose plots of untreated or monocytes 
treated with sense ODN to cPLA  2        showed random migration 
in the absence of MCP-1 and directed migration in the presence 
of MCP-1.   Migratory patterns of monocytes treated with 
(3,082.2      m) than unstimulated cells (1,722      m).   When treated 
with iPLA  2        antisense ODN, 98.7% reduction was observed in 
MCP-1  –  induced chemotaxis (  Fig. 3 A  ). These monocytes dis-
played reduced net distance (88%) in response to MCP-1 
(1,631.4      m) compared with MCP-1  –  stimulated cells that 
were not treated with ODN (  Fig. 3 B  ). Similarly, inhibition of 
cPLA  2        expression with antisense ODN caused 94% reduction 
in MCP-1  –  induced chemotaxis (  Fig. 3 A  ) and 84% inhibition of 
net distance traveled compared with ODN-untreated, MCP-1  –
  unstimulated cells (  Fig. 3 B  ). These observations suggest that, 
upon MCP-1 stimulation, more monocytes migrate toward 
MCP-1, and that migrating monocytes travel twice the distance 
compared with unstimulated cells. 
  iPLA  2        regulates both speed and directionality
of monocyte chemotaxis 
  Reduced net distance of migration of monocytes rendered 
defi  cient in phospholipase A  2   by antisense ODN, as described 
in the previous section, in response to MCP-1 (  Fig. 3 B  ) can 
be caused by a change in the total distance, speed, or net migra-
tion of monocytes toward MCP-1 (net-X distance). Therefore, 
the relative contribution of iPLA  2        and cPLA  2        to these 
    Figure 3.         iPLA  2        and cPLA  2              regulate chemotaxis to MCP-1 in 
the under-agarose assay.   Monocytes treated with antisense ODN of 
iPLA  2      or cPLA  2      were migrated for 1 h in response to MCP-1. Composite 
photomicrographs of the entire fi  eld of migration were reconstructed and 
used for determination of the number of migrating monocytes in the 
absence or presence of MCP-1 (A) and the net distance traveled by these 
migrating monocytes (B). The data are expressed as the mean   ±   the SEM 
from three independent experiments. Signifi  cance was determined by 
unpaired, one-tailed Student  ’  s   t   test.   352 PHOSPHOLIPASES IN MONOCYTE CHEMOTAXIS TO MCP-1 | Mishra et al.
  iPLA  2        regulates F-actin polymerization 
  MCP-1  –  induced recruitment of iPLA  2        to the F-actin  –  rich 
pseudopod and the signifi  cant loss of directionality of iPLA  2        
antisense ODN  –  treated monocytes suggested that iPLA  2        
might be involved in actin polymerization. We tested this 
possibility by evaluating the eff  ect of iPLA  2        inhibition on 
MCP-1  –  induced actin polymerization. MCP-1 induced a 
signifi  cant increase in the level of F-actin. Interestingly, in-
hi  bition of iPLA  2        by BEL caused signifi  cant reduction in 
F-actin levels (  Fig. 6 A  ).   Furthermore, iPLA  2        antisense 
ODN  –  treated monocytes displayed a signifi  cant reduction in 
actin polymerization compared with ODN-untreated or 
iPLA  2        sense ODN  –  treated monocytes (  Fig. 6 B  ). These ob-
servations indicate that iPLA  2        regulates MCP-1  –  induced 
actin polymerization. 
antisense ODN to cPLA  2        were more clustered than the other 
groups. Quantitative analysis of the migratory patterns of the 
maximum number of monocytes (  n  ) that could be tracked for 
60 min revealed that antisense ODN to cPLA  2        signifi  cantly 
reduced the speed of monocytes (3.96   ±   0.28      m/min) com-
pared with ODN-untreated, MCP-1  –  stimulated cells (7.58   ±   
0.62      m/min;   Fig. 5 B  ). cPLA  2        antisense ODN  –  treated cells 
also displayed signifi  cantly reduced net distance (  Fig. 5 C  ) and 
net migration toward MCP-1 (net  –  X distance;   Fig. 5 D  ) com-
pared with either no ODN or sense ODN  –  treated monocytes. 
Notably, cPLA  2        antisense ODN-treated cells displayed no 
signifi  cant reduction in the number of wide (  ≥  30 degrees) turns 
or the average angle per turn compared with controls (  Fig. 5, 
E and F ). These observations suggest that cPLA  2        regulates speed, 
but not directionality, of monocyte chemotaxis to MCP-1. 
    Figure 4.     iPLA  2        is required for normal speed and directionality of monocytes toward a gradient of MCP-1.   Monocytes were tracked at 
3-min intervals for 60 min in the presence or absence of MCP-1. (A) Wind  –  rose plots of monocytes untreated or treated with iPLA  2      ODN in the absence 
or presence of MCP-1. Representative migratory patterns of six monocytes are shown. The effect of iPLA  2      antisense ODN treatment on the speed (B), 
net distance (C), net-X (D), turns   ≥  30 degrees (E), and average angle/turn (F) of monocytes in the absence or presence of MCP-1.   n  , number of cells 
analyzed. Data are expressed as the mean   ±   the SEM. Statistical signifi  cance was calculated by Student  ’  s   t   test (unpaired, one-tailed [B  –  D] or unpaired, 
two-tailed [E and F]).     JEM VOL. 205, February 18, 2008 
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endogenous leukocytes of the recipient mouse to the perito-
neum will not be aff  ected (  Fig. 7 A  ).   
  Pharmacological inhibition of cPLA  2       /iPLA  2        suppresses 
monocyte migration in vivo.     Earlier, we reported that the 
iPLA  2   inhibitor racemic-BEL and the cPLA  2  /iPLA  2   inhibitor 
arachidonyl trifl  uoromethyl ketone (AACOCF  3  ) both sup-
pressed MCP-1 –  induced chemotaxis of primary monocytes ( 14  ). 
As predicted from these in vitro data, significantly fewer 
AACOCF  3  -treated monocytes migrated to the peritoneum in the 
adoptive transfer model (  Fig. 7 B  ). Surprisingly, no signifi  cant 
diff  erence was observed in the migration of monocytes treated 
with racemic-BEL compared with untreated monocytes. The 
ineffi   ciency of racemic-BEL to inhibit monocyte migration in 
vivo was found to be caused by time-dependent recovery of 
BEL-treated monocytes at 37  °  C in vitro (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20071243/DC1). 
  In vivo validation of the roles of iPLA  2        and cPLA  2     
  in monocyte chemotaxis 
  We developed a novel adoptive transfer mouse model to val-
idate the regulatory functions of iPLA  2        and cPLA  2        in 
monocyte chemotaxis to MCP-1 in vivo. It is based on the 
following: (a) migration of monocytes to the peritoneum in 
thioglycolate-induced peritonitis in wild-type mice is depen-
dent on MCP-1(7); (b) mouse peripheral blood mononuclear 
cell preparations do not contain neutrophils, and lymphocytes 
do not respond to MCP-1; (c) monocytes, by virtue of being 
fl  uorescently labeled with a stable PKH26, can be distinguished 
from unlabeled endogenous cells of the recipient mice; (d) we 
hypothesize that treatment of cells with phospholipase A  2    –
  specifi  c inhibitors or antisense ODNs before adoptive transfer 
will cause migration of fewer adoptively transferred monocytes; 
and (e) because adoptively transferred cells constitute only 
a small fraction of total blood cells (11  –  14%), migration of 
    Figure 5.         cPLA  2            maintains speed, but not directionality, of monocyte chemotaxis to MCP-1.   (A) Wind-rose plots of six representative mono-
cytes untreated or treated with cPLA  2      sense or antisense ODN. The effect of cPLA  2    -defi  ciency on the speed (B), net distance (C), net-X (D), turns   ≥  30 
deg (E), and average angle/turn (F) of monocytes in the presence or absence of MCP-1.   n  , number of the monocytes analyzed. Results shown are the 
mean   ±   the SEM. Statistical analysis was performed using Student  ’  s   t   test (unpaired, one-tailed [B  –  D] or unpaired, two-tailed [E and F]).     354 PHOSPHOLIPASES IN MONOCYTE CHEMOTAXIS TO MCP-1 | Mishra et al.
eff  ect of AACOCF  3   on cPLA  2        and iPLA  2       . As expected, 
no change was observed in either total monocytes or total 
leukocytes in the peritoneal lavage (  Fig. 7 B  ). 
  Phospholipase A  2   antisense ODN inhibits MCP-1  –  mediated 
chemotaxis of monocytes.     Because AACOCF  3   inhibits 
both iPLA  2   and cPLA  2   and racemic-BEL proved ineff  ective 
in vivo, we tested the effect of specific antisense ODNs. 
iPLA  2        antisense ODN used in this study has previously been 
demonstrated to reduce iPLA  2        protein expression in both 
murine and human monocytes/macrophages (  14, 18, 19  ). It 
signifi  cantly reduced the expression of iPLA  2        without af-
fecting cPLA  2        protein expression or enzyme activity (  14  ) 
and was eff  ective in reducing monocyte chemotaxis to MCP-1 
in vitro even 24 h later (unpublished data). Similarly, cPLA  2        
antisense ODN reduced monocyte chemotaxis in vitro with-
out aff  ecting iPLA  2        protein expression or enzyme activity (  14  ). 
It reduced the expression of cPLA  2        both in human and mu-
rine monocytes (Fig. S4, available at http://www.jem.org/
cgi/content/full/jem.20071243/DC1) (  14  ). 
  As shown (  Fig. 8 A  ), adoptively transferred monocytes 
treated with iPLA  2        antisense ODN displayed statistically 
signifi  cant reduction in migration to the peritoneum compared 
with untreated or sense ODN  –  treated monocytes (top).   
Migration of endogenous monocytes and total leukocytes 
To determine whether the apparent effi   cacy of AACOCF  3   in 
vivo was caused by toxicity, we examined monocyte sur-
vival and chemotaxis to MCP-1 24 h after treatment with 
AACOCF  3   in vitro. As shown in Fig. S3, AACOCF  3   treatment 
did not aff  ect monocyte survival, and the monocytes still dis-
played signifi  cant reduction in chemotaxis to MCP-1 compared 
with untreated monocytes. These observations suggest that 
eff  ectiveness of AACOCF  3   was caused by the stable inhibitory 
    Figure 6.         iPLA  2        regulates F-actin polymerization in primary hu-
man monocytes.   (A) Cells were left untreated or treated with racemic-
BEL (1      M for 1 h) and used to determine MCP-1  –  induced polymerization 
of actin. (B) Monocytes were left untreated or treated with sense (S-ODN) 
or antisense ODN (AS-ODN) of iPLA  2     . Data are the mean   ±   the SEM.   n   =  3. 
Signifi  cance was calculated by unpaired, one-tailed Student  ’  s   t   test.   
    Figure 7.     Pharmacological inhibition of PLA  2   reduces monocyte chemotaxis to MCP-1 in vivo.   (A) Schematic presentation of mouse peritonitis 
model used as in vivo chemotaxis assay of monocytes to MCP-1. (B) Mouse mononuclear cells left untreated or treated with racemic-BEL (1      m for 1 h) 
or AACOCF  3   (50      M for 1 h) were analyzed for migration to peritoneum in response to thioglycolate-induced peritonitis. Cells were scored for adoptively 
transferred monocytes (left), total monocyte/macrophage (middle), and total leukocytes (right). Data are the mean   ±   the SEM.   n   =  3.   JEM VOL. 205, February 18, 2008 
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    DISCUSSION   
  Our studies characterize the important relative contributions 
of cPLA  2        and iPLA  2        for regulating monocyte chemotaxis 
to MCP-1. Reduced migration of adoptively transferred, 
phospholipase-antisense ODN  –  treated mouse monocytes to 
the peritoneum in response to thioglycolate indicates the im-
portant signaling roles of iPLA  2        and cPLA  2        in monocyte 
chemotaxis to MCP-1 in vivo  .   
  The intracellular locations of these phospholipases vary 
with the type of cell and nature of stimulus. For example, in 
INS-1 cells, iPLA  2        translocates to the perinuclear region 
during endoplasmic reticulum stress or stimulation with glu-
cose (  20, 21  ), whereas in smooth muscles cells, iPLA  2        is as-
sociated with the plasma membrane (  22  ). Similarly, cPLA  2        
has been reported to be associated with the nuclear mem-
brane, Golgi complex, endoplasmic reticulum, plasma mem-
brane, and an undefi  ned intracellular compartment (  23  –  25  ). 
Our observations of the signifi  cant increase in colocalization 
of iPLA  2        with membrane and pseudopod markers and of 
cPLA  2        with the ER marker in nonpolar but MCP-1  –  stimu-
lated monocytes suggest that their recruitment to distinct 
intracellular locations is induced by MCP-1. This conclusion is 
further supported by the insignifi  cant colocalization of iPLA  2        
with cPLA  2       , and vice versa. 
  Earlier, we showed the restoration of chemotaxis of 
iPLA  2       -defi  cient monocytes to MCP-1 with LPA (  14  ). LPA has 
been reported to induce phospholipase D (PLD) activity, cy-
toskeleton rearrangements, and assembly of focal adhesions (  26  ). 
PLD can generate phosphatidic acid (PA) from membrane 
phospholipids (  27  ). Interestingly, PA is a preferred substrate of 
iPLA  2       , yielding LPA (  28  ).We have observed that PLD activ-
ity is induced by MCP-1 and required for monocyte chemo-
taxis (unpublished data). Furthermore, PLD is required for 
LPA-induced cytoskeletal rearrangements, likely through LPA 
formation (  27  ). As schematically represented in   Fig. 9  , these 
observations tempt us to speculate that in response to MCP-1, 
PLD acts on membrane phospholipids to generate PA, and then 
iPLA  2        acts on PA to liberate LPA.   LPA possibly interacts 
with components of pseudopod assembly and regulates cyto-
skeletal reorganization; hence, speed and directionality of 
monocytes. This conjecture is reinforced by observations that 
actin polymerization is spatially localized to the membrane-
enriched pseudopod, where iPLA  2        is recruited in response 
to MCP-1 (  Fig. 1, B and C  ), MCP-1 induces association of 
iPLA  2        with F-actin, irrespective of cell polarity (  Fig. 1 D  ), and 
MCP-1  –  induced actin polymerization is signifi  cantly reduced 
in response to iPLA  2        inhibition or reduced expression (  Fig. 6  ). 
  MCP-1 chemotaxis can be restored in cPLA  2       -defi  cient 
monocytes by AA ( 14  ). Thus, cPLA  2        may contribute to mono-
cyte migration by generating AA in the endoplasmic reticulum 
(  Fig. 9  ). AA can be converted into various metabolites, such 
as prostaglandins, lipoxins, LTB4, and H(P)ETEs via COX-2, 
cytochrome P450, or lipoxygenase pathways (  29  ). Lipoxins 
induce RhoA- and Rac-mediated actin reorganization in 
monocytes/macrophages (  30  ), whereas prostaglandin 2 increases 
migration of dendritic cells (  31  ). Our observations, in view of 
remained statistically similar. These data suggest that unlike 
racemic-BEL, iPLA  2        antisense ODN  –  treated monocytes 
displayed sustained reduced migration in vivo. 
  To evaluate the in vivo requirement for cPLA  2        in MCP-1 
chemotaxis, adoptively transferred cells were pretreated with 
antisense ODN to cPLA  2        and monitored for their response 
to thioglycolate. As shown in   Fig. 8 B   (top), signifi  cantly 
fewer cPLA  2        antisense ODN  –  treated cells migrated to the 
peritoneum compared with untreated or cPLA  2        sense ODN  –
  treated cells. As expected, infi  ltration of monocytes (  Fig. 8 B  , 
middle) or total leukocytes (  Fig. 8 B  , bottom) remained un-
aff  ected in animals that received either untreated or cPLA  2        
sense ODN  –  treated cells. These results demonstrate that 
iPLA  2        and cPLA  2        are required for MCP-1  –  induced chemo-
taxis of monocytes in vivo, thus validating our previous 
in vitro fi  ndings. 
    Figure 8.     Reduced migration of iPLA  2        or cPLA  2          AS-ODN  –
  treated mouse monocytes in vivo.   (A) Mouse peripheral blood mono-
nuclear cells left untreated or treated with sense (S) or antisense (AS) 
ODN (5      m) to iPLA  2      (37  °  C for 24 h) were injected into the recipient 
mice (1.87 million/recipient). Peritonitis was initiated with thioglycolate. 
Cells were harvested from the peritoneum after 24 h and scored for 
PKH26-positive cells (top), monocytes (middle), and total leukocytes (bottom). 
(B) Mouse mononuclear cells left untreated or treated with cPLA  2      sense 
or antisense ODN were adoptively transferred to recipient mice. Peritonitis 
was initiated with thioglycolate. After 24 h, peritoneal cells were isolated 
and scored as indicated in A. Data are the mean   ±   the SEM.   n   =  number 
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only controls morphological and invasion characteristics of 
macrophages (  37  ). Vav1 is supposed to control the speed of 
migrating macrophages (  38  ). In neutrophils, defi  ciency of Rho 
GEF Lsc causes faster migration and loss of directionality (  39  ), 
whereas defi  ciency of PI3K      causes only loss of directional-
ity (  40  ). In   Dictyostelium discoideum,   PTEN regulates levels of 
PtdIns(3,4,5)P  3  ; in contrast, in neutrophils, it is metabolized 
by the PtdIns(3,4,5)P  3   phosphatase SHIP1 rather than PTEN. 
These observations not only point toward evolution of cell-based 
variability in key signaling molecules, they also provide an impe-
tus to search for unknown members of these cascades (  41, 42  ). 
  Once considered a probable cellular compass, recent re-
ports suggest that PtdIns(3,4,5)P  3   is primarily a component of 
positive-feedback loop controlling persistent actin dynam-
ics (  43  ). Emerging concepts argue for the existence of parallel 
signaling pathways for chemotaxis and indicate that an un-
known cellular compass exists upstream of PI3K      (  42, 44  ). 
Interestingly, a calcium-independent phospholipase (PLA  2  A) 
that liberates AA from phosphatidylcholine and acts in parallel 
with PI3K/PTEN has recently been implicated in chemotaxis 
of   D. discoideum   (  45  ). Because iPLA  2   does not show a prefer-
ence for the fatty acyl moiety at the sn-2 position of phospho-
lipids, and  D. discoideum   does not contain cPLA  2       , it is possible 
that PLA  2  A merely performs twin functions of cPLA  2        and 
iPLA  2        by liberating LPA and AA. Our observations on loss 
of directionality of iPLA  2       -defi  cient monocytes raise the pos-
sibility that iPLA  2        is either a cellular compass or a component 
of a cellular compass. Our observations, together with recent 
reports (  44, 45  ), suggest that phospholipases are critical com-
ponents of parallel signaling pathways regulating monocyte 
chemotaxis as schematically represented in  Fig. 9 . How iPLA  2        
directs monocytes toward MCP-1, as well as whether it is a 
universal regulator of chemotaxis, remains to be deciphered. 
One key function ascribed to iPLA  2        is membrane remodel-
ing and membrane traffi   cking that brings about changes in 
shape and fl  uidity of the plasma membrane (  46  ). It will be 
interesting to explore whether iPLA  2        regulates monocyte 
chemotaxis by changing lipid composition of membrane rafts, 
thereby modifying assembly of signaling molecules in the 
pseudopod of migrating cells (  47  ). 
  The impaired in vivo migration of adoptively trans-
ferred mouse monocytes that contain either inactive PLA  2   (by 
AACOCF  3  ) or were rendered defi  cient in PLA  2   by AS-ODN 
validates our in vitro observations (  14  ) in a dynamic in vivo 
milieu. We now have adapted this in vivo assay to monitor 
human monocyte chemotaxis (  48  ). Our reports show the 
importance of in vitro studies for identifi  cation of potential 
signaling components. Our in vivo MCP-1 chemotaxis assay 
provides a straightforward approach to verify the relevance 
of signaling pathways that appear promising for regulating 
MCP-1  –  dependent chemotaxis in vitro. 
  In summary, our studies provide insight into how two 
seemingly similar phospholipases regulate directed migration 
of monocytes from diff  erent intracellular sites. We report that 
MCP-1 induces chemotaxis of monocytes by increasing speed, 
as well as introducing directionality. By translocating to the 
these reports, call for identifi  cation of key metabolites of AA 
that regulate monocyte migration to MCP-1. 
  Directed cell migration is initiated by sensing of chemo-
tactic stimuli, and culminates in the directed migration of cells. 
During this process, an external shallow gradient of chemo-
kine is perceived, translated, and amplifi  ed into a stable intra-
cellular gradient of signaling molecules that results in the 
formation of pseudopod at the front and uropod in the rear of 
a migrating cell. The pseudopod is formed by the activation 
of the heterotrimeric GTP binding protein Gi, whereas the 
uropod is formed by the activation of heterotrimeric GTP-
binding protein G  12/13  . Phosphatidylinositol (3,4,5) triphosphate 
(PtdIns[3,4,5]P  3  ), a key lipid messenger, is synthesized in the 
leading edge by PI(3)Ks and is degraded by PTEN in the rear 
edge of migrating cells (  32  ). This vectorial metabolism gives 
rise to an intracellular gradient of PtdIns(3,4,5)P  3  . Pseudopod 
is organized by Rac/PtdIns(3,4,5)P  3  /actin and is stabilized by 
the scaff  old Hem-1 (  33, 34  ). In contrast, the uropod is orga-
nized by Rho-mediated, myosin-based contractions (  35  ). 
This distinct intracellular hierarchy is thought to commence 
polarity and ensure directed migration of cells in a chemokine 
gradient. Multiple signaling molecules are believed to orches-
trate these distinct events at the opposing edges of a migrating 
cell. For example, Cdc42 regulates stability and location of the 
leading edge, whereas Rac, which transforms random migration 
of fi  broblasts and epithelial cells to directed migration (  36  ), 
    Figure 9.     Schematic presentation of the roles of phospholipases 
A  2   and their lipid products in monocyte chemotaxis to MCP-1.   Rec-
ognition of MCP-1 by CCR2 activates parallel signaling pathway mediated 
by iPLA  2      and cPLA  2    .  iPLA 2      translocates to the pseudopod and regu-
lates directionality and speed, likely by regulating actin polymerization 
and thereby inhibiting monocyte chemotaxis. cPLA  2      translocates to the 
endoplasmic reticulum and regulates monocyte speed through AA or its 
metabolites. Both enzymes regulate the net migration of monocytes; 
therefore, defi  ciency of either of them inhibits chemotaxis of monocytes.     JEM VOL. 205, February 18, 2008 
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    Time-lapse microscopy 
  For this purpose, under-agarose cell migration was performed in serum-coated 
polystyrene six-well culture dishes, essentially as described in the previous 
section. The plate was placed on a preheated stage at 37  °  C under 10% CO  2  . 
Images were acquired with an inverted microscope (DMIRB; Leica) using a 
10  ×   phase objective. Images were acquired at 3-min intervals using 30-ms expo-
sure times and recorded with a cooled charge-coupled device camera (Cool 
SNAP HQ; Roper Scientifi  c) using Metamorph software (Universal Image). 
  Image analysis   
  Image analysis was conducted with Image-Pro Plus. In the absence of MCP-1, 
randomly migrating cells often return to the well where they originated. Because 
of the large number of cells in the well itself, returning cells could not be fol-
lowed after reentering the well. Therefore, cells that can be tracked for the 
60-min duration were used for migration analysis. Total distance depicts total 
length of a migratory path, speed denotes total distance/60 min, and net dis-
tance depicts the linear distance between the fi  rst and the last position of a mi-
grating cell. Net-X is the net value of the X coordinate after 60 min. The turn 
angle is the absolute value of the angle between successive positions of migrat-
ing cell measured from the direction of the preceding position. Average an-
gle/turn depicts the average angles of the turns taken by a migrating cell during 
60 min of migration at 3-min intervals. 
  Quantifi  cation and colocalization of phospholipases 
  Mean fl  uorescent intensity of iPLA  2        in tail, midbody, and pseudopod of polar 
cells was determined by measuring pixel intensity of iPLA  2        and area clearly 
demarcated based on cellular morphology shown by diff  erential interference 
contrast (DIC) images using Image-Pro Plus. Colocalization (percentage) of 
enzymes with marker proteins were determined as previously described (  51  ). 
    Determination of F-actin 
  This assay was used to determine the eff  ect of iPLA  2        inhibition on F-actin 
polymerization, as described by Finkel et al. (  52  ) using 2 million cells. 
  Isolation of mouse peripheral blood mononuclear cells   
  Animals (BALB/CJ; Jackson ImmunoResearch Laboratory) were used ac-
cording to the protocol approved by the Cleveland Clinic Foundation Insti-
tutional Animal Care and Use Committee. BALB/CJ female mice (7  –  8 mo, 
two donors per recipient) were anesthetized with avertin (0.4 ml/animal). 
Blood was collected by cardiac puncture in a 1-ml syringe containing 0.05 ml of 
EDTA (0.5 M). Blood (10 ml) was diluted with 10 ml of Tricine-buff  ered saline 
(TBS; 10 mM, pH 7.4) and mixed with 5 ml of OptiPrep (Sigma-Aldrich). 
Blood was transferred to a suitable tube, overlayed with 0.5 ml of TBS and 
centrifuged at 1,000   g   for 30 min at 20  °  C without the brake. The supernatant, 
containing mononuclear cells, was collected, diluted with 2 volumes of TBS, 
and centrifuged at 400   g   for 10 min. The pellet was reconstituted in 0.5 ml of 
TBS, layered on dialyzed calf serum (2 ml), and centrifuged at 200   g   for 15 min 
to remove platelets. Cells were suspended in TBS and counted. The recovery 
of mononuclear cells by this method was 7.45   ×   10  4  /g mouse. 
    Fluorescent labeling of mononuclear cells with PKH26 
  Cells were labeled per the manufacturer  ’  s instructions. Cells were suspended 
in DMEM and treated with inhibitors as previously described (  14  ). 
  Adoptive transfer of mononuclear cells and initiation of peritonitis   
  Recipient mice (3  –  4 per group) were lightly anesthetized with avertin. Perito-
neal infl  ammation was induced by thioglycolate injection (1 ml, 4% in physi-
ological saline) into the peritoneal cavity. Tail veins were dilated with limonene 
and cleaned with 95% ethanol. The labeled mononuclear cells (1.4  –  1.8 million 
per animal) were injected into the tail vein, and the time of injection was re-
corded. Injected cells represent only 11  –  14% of total peripheral blood mono-
nuclear cells of similar weight recipient animals. After 24 h, peritoneal cells 
were harvested, washed, resuspended in PBS (1 ml), and counted. Cells were 
fi  xed and used to prepare 10 cytospins for each sample. Half of them were 
pseudopod and regulating directionality and speed, iPLA  2        
acts front and center, whereas in contrast, cPLA  2        is recruited 
to the endoplasmic reticulum and regulates only speed. The 
profound defects in migration of iPLA  2       - or cPLA  2       -defi  -
cient mouse monocytes in vivo validate the important roles 
for these enzymes in regulating extravasation of blood mono-
cytes to sites of infl  ammation. 
    MATERIALS AND METHODS   
  Antibodies and reagents 
  BEL and AACOCF  3   were obtained from Biomol. Bel enantiomers (R and S) 
were provided by R. Gross (Washington University School of Medicine, 
St. Louis, MO). Human recombinant MCP-1 (BD Biosciences) was used at a 
concentration of 5.75 nM. Anti-iPLA  2            (1:50; goat polyclonal), anti  –  human 
Cdc-42 (1:50; rabbit polyclonal), and anti  –  human PDI (1:100; rabbit poly-
clonal) were purchased from Santa Cruz Biotechnology. Anti  –  human cPLA  2        
(rabbit polyclonal) and a mouse monoclonal antibody against human Na-K 
ATPase (1:200) were obtained from Cell Signaling Technology. Rhodamine 
phalloidin (1:40), Rab5, lectin GSII-Alexa Fluor 594, and Alexa Fluor 594  –   
or 488  –  tagged species-specifi  c secondary antibody raised in donkey (1:200) 
were obtained from Invitrogen. 
    Isolation of human monocytes and cell culture 
  Human monocytes were isolated from freshly drawn human whole blood, as 
described by McNally et al. (  49  ), and maintained in DME (10% BCS) in 
polypropylene tubes at 2   ×   10  6   cells/ml. Studies on human monocytes were 
approved by the Institutional Review Board of the Cleveland Clinic. 
  Chemotaxis assays   
  Microchamber chemotaxis assay.     This assay was performed as previously 
described (  14  ) and was used to quantify monocyte migration to MCP-1. 
  Under-agarose cell migration assay.     The under-agarose cell migra-
tion assay was performed as described by Heit and Kubes (  50  ) using 10% 
BCS containing DME. Net distance in this assay denotes the distance 
between the edge of the well and the fi  nal position of migrating cells. It 
was determined from the composite photomicrograph of the entire fi  eld 
of migration. 
    Treatment of monocytes with pharmacological inhibitors
and antisense ODNs 
  Monocytes were pretreated with Racemic-BEL or its R or S enantiomers 
(0.1  –  5      M) or AACOCF  3   (50      M) at 37  °  C in 10% CO  2   for 1 h, and washed 
in serum-free DME before being used for chemotaxis. The sense and anti-
sense ODN sequences for phospholipases used in this study were phosphoro-
thioate modifi  ed and purifi  ed by HPLC (Sigma-Aldrich). These ODNs were 
of proven effi   cacy and specifi  city, and were delivered under standardized ex-
perimental conditions, as described (  14  ). These specifi  c antisense ODNs were 
eff  ective in reducing the expression of iPLA  2        or cPLA  2       , as described in our 
previous study (  14  ). 
  Immunostaining and confocal microscopy   
  Monocytes were allowed to migrate using the under-agarose cell migration 
assay (1 h), fi  xed, and permeabilized with Triton X-100 (0.1% in PBS for 
4 min). Nonspecifi  c sites were blocked with 3% BSA in PBS (37  °  C for 1 h). 
Cells were incubated with primary antibody (for 1 h at 37  °  C), washed, and 
visualized with fl  uorescently labeled secondary antibody (for 1 h at 37  °  C). 
Stained cells were mounted in Vectashield (Vector Laboratories) and ob-
served using a laser-scanning confocal microscope (DMR XE attached to 
TCS SP2; Leica). Horizontal sections were imaged using a 63  ×   objective 
(magnifi  cation 5  ×  , pinhole 1, and format of 1,024   ×   1,024). Images were 
analyzed by Image-Pro Plus (Media Cybernetics) and processed using Pho-
toshop CS (Adobe). 358 PHOSPHOLIPASES IN MONOCYTE CHEMOTAXIS TO MCP-1 | Mishra et al.
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